Dyne Therapeutics, Inc. (DYN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

26.00

+0.05

(+0.19%)

At close: 04:00PM EDT

26.12

+0.12

(+0.46%)

After hours:

06:14PM EDT

Loading interactive chart…

Simply Wall St.
We're Hopeful That Dyne Therapeutics (NASDAQ:DYN) Will Use Its Cash Wisely
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
GuruFocus.com
Dyne Therapeutics Inc (DYN) Q1 2024 Earnings: Aligns with Analyst Projections
Overview of Financial Performance and Future Prospects
GlobeNewswire
Dyne Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
- Additional Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Anticipated in the Second Half of 2024 - WALTHAM, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today reported financial results for the first quarter of 2024 and recent business highlights. “I am excited about